Report: DoJ sues Walmart over role in opiod crisis - Breaking The News
Download our appPlay StoreApp Store

Report: DoJ sues Walmart over role in opiod crisis

EPA-EFE/LARRY W. SMITH

The Department of Justice filed a lawsuit against retail giant Walmart on Tuesday over its alleged role in fueling the opioid crisis in the United States, the Wall Street Journal reported.

According to the lawsuit, which was expected for months, Walmart's pharmacists are accused of filling opioid prescriptions that were deemed suspicious, in an effort to boost profits and under pressure from the company.

Walmart sued the federal government pre-emptively in October, asking for clarification on the legal responsibilities of pharmacists and pharmacies in filling opioid prescriptions. Shares of Walmart were down 1.65% to $143.56 shortly following the news.

Related Stocks
Wal-Mart Stores
Related News
Walmart's revenue up 4.1% to $180.6B in Q4
Walmart Inc. announced on Thursday that revenue for the fourth quarter of fiscal 2025 climbed 4.1% to $180.6 billion, beating market expectations. For the same three-month period, the company said that operating income surged by 8.3% to $0.6 billion.For the full fiscal year, Walmart's revenue climbed to $681 billion, a 5.1% increase, while its operating income rose to $2.3 billion, marking a 8.6% growth. The company's return on assets (ROA) stood at 7.9%, and...
Earnings preview: Chinese giants take center stage
During this week, a slew of companies from across the globe are expected to release their latest quarterly results, with Chinese giants in the center of happenings.Alibaba, which surged over 68% on an annual basis, is to unveil its financial report on February 20, with analysts seeing the company's earnings per share (EPS) growing by 24% in 2025. The e-commerce's investment in artificial intelligence (AI) technology is likely to push its stock higher this year,...
Target to end DEI initiatives
Target Corporation's Chief Community Impact and Equity Officer Kiera Fernandez shared in a memo on Friday that the company will reduce its diversity, equity, and inclusion (DEI) initiatives.The memo seen by CNCB showed that Target will discontinue its three-year DEI objectives, stop reporting to diversity organizations like the Human Rights Campaign's Corporate Equality Index, and end a program focused on increasing products from Black- and...
Purdue Pharma owners to pay up to $7.4B in opioid settlement
New York Attorney General Letitia James announced on Thursday that the Sackler family members, who own the OxyContin maker Purdue Pharma, reached a settlement to pay up to $7.4 billion "for their instrumental role in creating the opioid crisis."According to the new settlement, the Purdue Pharma owners will contribute up to $7.4 billion over the span of 15 years, with a portion of the money going to the victims of the opioid crisis. The first payment of $1.5...

Please observe our Terms of Use. The price information is time delayed to varying extents, but as a rule by 15 minutes or more, according to the regulations of the selected stock exchange and/or licensors and the type of securities.

© 2025 TeleTrader Software GmbH. All rights reserved

This website uses cookies to ensure you get the best experience. Our Terms of Use and Data Protection Policy explain the data we collect, why we collect them, and how we may share them.